These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 28073883)

  • 1. Infective endocarditis and risk of death after cardiac implantable electronic device implantation: a nationwide cohort study.
    Özcan C; Raunsø J; Lamberts M; Køber L; Lindhardt TB; Bruun NE; Laursen ML; Torp-Pedersen C; Gislason GH; Hansen ML
    Europace; 2017 Jun; 19(6):1007-1014. PubMed ID: 28073883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival in Women Versus Men Following Implantation of Pacemakers, Defibrillators, and Cardiac Resynchronization Therapy Devices in a Large, Nationwide Cohort.
    Varma N; Mittal S; Prillinger JB; Snell J; Dalal N; Piccini JP
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28490521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infections and associated costs following cardiovascular implantable electronic device implantations: a nationwide cohort study.
    Clémenty N; Carion PL; Léotoing L; Lamarsalle L; Wilquin-Bequet F; Brown B; Verhees KJP; Fernandes J; Deharo JC
    Europace; 2018 Dec; 20(12):1974-1980. PubMed ID: 29672690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and Costs Related to Lead Damage Occurring Within the First Year After a Cardiac Implantable Electronic Device Replacement Procedure.
    Nichols CI; Vose JG; Mittal S
    J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26873688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of device-related infection in 97 750 patients: clinical data from the complete Danish device-cohort (1982-2018).
    Olsen T; Jørgensen OD; Nielsen JC; Thøgersen AM; Philbert BT; Johansen JB
    Eur Heart J; 2019 Jun; 40(23):1862-1869. PubMed ID: 31155647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence, indications, risk factors, and survival of patients undergoing cardiac implantable electronic device implantation after open heart surgery.
    Wiggins NB; Chong DT; Houghtaling PL; Hussein AA; Saliba W; Sabik JF; Wazni O; Wilkoff BL; Tarakji KG
    Europace; 2017 Aug; 19(8):1335-1342. PubMed ID: 27738074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rate, causes, and impact on patient outcome of implantable device complications requiring surgical revision: large population survey from two centres in Italy.
    Palmisano P; Accogli M; Zaccaria M; Luzzi G; Nacci F; Anaclerio M; Favale S
    Europace; 2013 Apr; 15(4):531-40. PubMed ID: 23407627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Device infections in implantable cardioverter defibrillators versus permanent pacemakers: A systematic review and meta-analysis.
    Rattanawong P; Kewcharoen J; Mekraksakit P; Mekritthikrai R; Prasitlumkum N; Vutthikraivit W; Putthapiban P; Dworkin J
    J Cardiovasc Electrophysiol; 2019 Jul; 30(7):1053-1065. PubMed ID: 30938929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac implantable electronic device and associated risk of infective endocarditis in patients undergoing aortic valve replacement.
    Østergaard L; Valeur N; Bundgaard H; Gislason G; Torp-Pedersen C; Eske Bruun N; Køber L; Fosbøl EL
    Europace; 2018 Oct; 20(10):e164-e170. PubMed ID: 29294002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venous thromboembolism in patients with implantable cardioverter-defibrillators.
    Pedersen SB; Hjortshøj SP; Bøtker HE; Farkas DK; Schmidt M; Sørensen HT; Nielsen JC
    Europace; 2017 Jun; 19(6):991-1001. PubMed ID: 27256414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complications in recipients of cardioverter-defibrillator or cardiac resynchronization therapy: Insights from Silesian Center Defibrillator registry.
    Tajstra M; Gadula-Gacek E; Kurek A; Adamowicz-Czoch E; Olszowski D; Ostręga M; Ciślak A; Pyka Ł; Hawranek M; Lekston A; Poloński L; Gąsior M
    Cardiol J; 2017; 24(5):515-522. PubMed ID: 27734455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome in patients undergoing upgrade to cardiac resynchronization therapy: predictors of outcome after upgrade to CRT.
    Kosiuk J; Krause M; Doering M; Weber A; Breithardt OA; Dinov B; Darma A; Lucas J; Muessigbrodt A; Bode K; Kuehl M; Dagres N; Hindricks G; Bollmann A; Richter S
    Heart Vessels; 2020 Jan; 35(1):104-109. PubMed ID: 31227877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased late complex device infections are determined by cardiac resynchronization therapy-defibrillator infection.
    Unsworth JD; Zaidi A; Hargreaves MR
    Europace; 2015 Nov; 17(11):1708-11. PubMed ID: 25883081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeated procedures at the generator pocket are a determinant of implantable cardioverter-defibrillator infection.
    Arana-Rueda E; Pedrote A; Frutos-López M; Acosta J; Jauregui B; García-Riesco L; Arce-León Á; Gómez-Pulido F; Sánchez-Brotons JA; Gutiérrez-Carretero E; de Alarcón-González A
    Clin Cardiol; 2017 Oct; 40(10):892-898. PubMed ID: 28636098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac implantable electronic device and vascular access: Strategies to overcome problems.
    Kusztal M; Nowak K
    J Vasc Access; 2018 Nov; 19(6):521-527. PubMed ID: 29552930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients upgraded to cardiac resynchronization therapy due to pacing-induced cardiomyopathy are at low risk of life-threatening ventricular arrhythmias: a long-term cause-of-death analysis.
    Barra S; Duehmke R; Providencia R; Marijon E; Boveda S; Virdee M; Heck P; Fynn S; Begley D; Grace A; Agarwal S
    Europace; 2018 Jan; 20(1):89-96. PubMed ID: 28031276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark.
    Kirkfeldt RE; Johansen JB; Nohr EA; Jørgensen OD; Nielsen JC
    Eur Heart J; 2014 May; 35(18):1186-94. PubMed ID: 24347317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adding the implantable cardioverter-defibrillator to cardiac resynchronization therapy is associated with improved long-term survival in ischaemic, but not in non-ischaemic cardiomyopathy.
    Witt CT; Kronborg MB; Nohr EA; Mortensen PT; Gerdes C; Jensen HK; Nielsen JC
    Europace; 2016 Mar; 18(3):413-9. PubMed ID: 26378089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased long-term mortality in patients with cardiovascular implantable electronic device infections.
    Rizwan Sohail M; Henrikson CA; Jo Braid-Forbes M; Forbes KF; Lerner DJ
    Pacing Clin Electrophysiol; 2015 Feb; 38(2):231-9. PubMed ID: 25243484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of infective endocarditis in patients considered at moderate risk.
    Østergaard L; Valeur N; Wang A; Bundgaard H; Aslam M; Gislason G; Torp-Pedersen C; Bruun NE; Søndergaard L; Køber L; Fosbøl EL
    Eur Heart J; 2019 May; 40(17):1355-1361. PubMed ID: 30346503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.